<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T03:10:23Z</responseDate>
  <request identifier="oai:figshare.com:article/34034832" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034832</identifier>
        <datestamp>2026-09-30T17:28:14Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;PRISMA-P-checklist.&lt;/p&gt;</dc:title>
          <dc:creator>Philmon Dejen (20308535)</dc:creator>
          <dc:creator>Belay Beyene (4098613)</dc:creator>
          <dc:creator>Tizazu Zenebe Zelelie (16455663)</dc:creator>
          <dc:creator>Amanuel Kelem (15910221)</dc:creator>
          <dc:creator>Abiel Teshome (25145136)</dc:creator>
          <dc:creator>Mahider Ayalew (25145139)</dc:creator>
          <dc:creator>Techalew Shimelis (3599390)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>two independent reviewers</dc:subject>
          <dc:subject>remain clinically silent</dc:subject>
          <dc:subject>quality assessment using</dc:subject>
          <dc:subject>inform targeted interventions</dc:subject>
          <dc:subject>including google scholar</dc:subject>
          <dc:subject>comprehensive literature search</dc:subject>
          <dc:subject>african journals online</dc:subject>
          <dc:subject>based malaria surveillance</dc:subject>
          <dc:subject>generate comprehensive evidence</dc:subject>
          <dc:subject>conduct study selection</dc:subject>
          <dc:subject>support malaria control</dc:subject>
          <dc:subject>malaria transmission due</dc:subject>
          <dc:subject>plasmodium species distribution</dc:subject>
          <dc:subject>2 &lt;/ sup</dc:subject>
          <dc:subject>actual data collection</dc:subject>
          <dc:subject>analysis &lt;/ p</dc:subject>
          <dc:subject>malaria control</dc:subject>
          <dc:subject>species distribution</dc:subject>
          <dc:subject>data collection</dc:subject>
          <dc:subject>asymptomatic malaria</dc:subject>
          <dc:subject>transmission season</dc:subject>
          <dc:subject>synthesize evidence</dc:subject>
          <dc:subject>study design</dc:subject>
          <dc:subject>study area</dc:subject>
          <dc:subject>data extraction</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>subgroup analyses</dc:subject>
          <dc:subject>risk factors</dc:subject>
          <dc:subject>q test</dc:subject>
          <dc:subject>prespecified factors</dc:subject>
          <dc:subject>potential reservoir</dc:subject>
          <dc:subject>partial immunity</dc:subject>
          <dc:subject>p guidelines</dc:subject>
          <dc:subject>major challenge</dc:subject>
          <dc:subject>increasingly recognized</dc:subject>
          <dc:subject>frequent exposure</dc:subject>
          <dc:subject>epidemiological importance</dc:subject>
          <dc:subject>endemic settings</dc:subject>
          <dc:subject>elimination strategies</dc:subject>
          <dc:subject>elimination efforts</dc:subject>
          <dc:subject>eligible studies</dc:subject>
          <dc:subject>electronic databases</dc:subject>
          <dc:subject>diagnostic method</dc:subject>
          <dc:subject>analysis aim</dc:subject>
          <dc:subject>allows infections</dc:subject>
          <dc:subject>aged children</dc:subject>
          <dc:description>&lt;div&gt;
&lt;p&gt;Background&lt;/p&gt;&lt;p&gt;Asymptomatic malaria infection remains a major challenge for malaria control and elimination efforts, particularly in endemic settings such as Ethiopia. School-aged children are increasingly recognized as a potential reservoir for malaria transmission due to frequent exposure to infection and the development of partial immunity that allows infections to remain clinically silent. However, available evidence on the burden, species distribution, and determinants of asymptomatic malaria in this population is fragmented and inconsistent. This systematic review and meta-analysis aim to synthesize evidence on the prevalence, Plasmodium species distribution, and risk factors of asymptomatic malaria among school-aged children in Ethiopia.&lt;/p&gt;
&lt;p&gt;Methods&lt;/p&gt;&lt;p&gt;This protocol was developed in accordance with the PRISMA-P guidelines. A comprehensive literature search will be conducted in electronic databases (PubMed, Scopus, CINAHL, and ScienceDirect) and additional sources, including Google Scholar and African Journals Online. Eligible studies will include observational studies reporting asymptomatic malaria among school-aged children in Ethiopia. Two independent reviewers will conduct study selection, data extraction, and quality assessment using the Joanna Briggs Institute critical appraisal tool for prevalence studies. A random-effects meta-analysis will be performed using R software to estimate the pooled prevalence. Heterogeneity will be assessed using Cochran’s Q test and I&lt;sup&gt;2&lt;/sup&gt; statistics, and subgroup analyses will be conducted by diagnostic method, study area, study design, years of actual data collection, and transmission season during data collection. Where sufficiently comparable adjusted estimates are available, associations between prespecified factors and AMI will also be quantitatively synthesized.&lt;/p&gt;
&lt;p&gt;Conclusion&lt;/p&gt;&lt;p&gt;The findings will generate comprehensive evidence to support malaria control and elimination strategies in Ethiopia by highlighting the epidemiological importance of school-aged children as a potential reservoir for infection. The results are expected to inform targeted interventions and strengthen school-based malaria surveillance and prevention programs.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-30T17:28:11Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1371/journal.pone.0359714.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/_p_PRISMA-P-checklist_p_/34034832</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
